The return on R&D versus capital expenditures in pharmaceutical and chemical industries

IEEE Transactions on Engineering Management

Volumn 50, Issue 2, 2003, Pages 141-150

  Hsieh, Ping Hung ^a   Mishra, Chandra S ^b   Gobeli, David H ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b ROLLINS COLLEGE   (United States)

Author keywords

Capital expenditures; Corporate strategy; Firm performance; Market value; Net margin; Operating margin; Parks regression; Research and development (R D); Resource based theory; Sales growth; Tobin's Q

Indexed keywords

CHEMICAL INDUSTRY; DRUG PRODUCTS; INVESTMENTS; MARKETING; MATHEMATICAL MODELS; PERFORMANCE; REGRESSION ANALYSIS; SALES; STRATEGIC PLANNING;

CAPITAL EXPENDITURES; CORPORATE STRATEGY; FIRM PERFORMANCE; MARKET VALUE; OPERATING MARGIN; PROFITABILITY; RESOURCE-BASED THEORY;

RESEARCH AND DEVELOPMENT MANAGEMENT;

EID: 0038271976     PISSN: 00189391     EISSN: None     Source Type: Journal    
DOI: 10.1109/TEM.2003.810828     Document Type: Article

References (46)

1. T. W. Anderson and C. Hsiao, "Formulation and estimation of dynamic models using panel data," J. Econometrics, vol. 18, pp. 47-82, Jan. 1982.
2. M. N. Baily, "Research development costs and returns: The U.S. pharmaceutical industry," J. Pol. Econ., pp. 70-85, Jan./Feb. 1972.
3. J. Barney, "Firm resources and sustained competitive advantage," J. Manage., vol. 17, no. 1, pp. 99-120, 1991.
4. N. Beck and J. N. Katz, "What to do (and not to do) with time-series cross-section data," Amer. Pol. Sci. Rev., vol. 89, pp. 634-647, Sept. 1995.
5. A. S. Bharadwaj, S. G. Bharadwaj, and B. R. Konsynski, "Information technology effects on firm performance as measured by Tobin's Q," Manage. Sci., vol. 45, pp. 1008-1024, June 1999.
6. B. Branch, "Research and development activity and profitability: A distributed lag analysis," J. Pol. Econ., vol. 82, pp. 999-1011, 1974.
7. M. S. Brenner and B. M. Rushton, "Sales Growth and R&D in the Chemical Industry," Res. Technol. Manage., vol. 32, pp. 8-15, Mar./Apr. 1989.
8. K. H. Chung and S. W. Pruitt, "A simple approximation of Tobin's Q," Fin. Manage., vol. 23, pp. 70-74, 1994.
9. R. A. Connolly and H. Hirschey, "R&D, market structure, and profits: A value-based approach," Rev. Econ. Stat., vol. 66, pp. 682-686, Nov. 1984.
10. I. Dierickx and K. Cool, "Asset stock accumulation and sustainability of competitive advantage," Manage. Sci., vol. 35, no. 12, pp. 1504-1511, 1989.
11. S. S. Dugal and G. K. Morbey, "Revisiting corporate R&D spending during a recession," Res. Technol. Manage., vol. 38, pp. 23-27, July/Aug. 1995.
12. G. Erickson and R. Jacobson, "Gaining comparative advantage through discretionary expenditures: The returns to R&D and advertising," Manage. Sci., vol. 38, pp. 1264-1279, Sept. 1992.
13. D. H. Gobeli, C. S. Mishra, and H. F. Koenig, "Strategic value of technology and brand equity for multinational firms," in Valuation of Intangible Assets in Global Operations, F. J. Contractor, Ed. Westport, CT: Quorum, 2001, pp. 321-333.
14. H. Grabowski, "An analysis of U.S. international competitiveness in pharmaceuticals," Manag. Decision Econ., pp. 27-33, 1989.
15. H. Grabowski and D. Mueller, "Industrial research and development, intangible capital stocks, and firm profit rates," Bell J. Econ., vol. 9, pp. 328-343, Autumn 1978.
16. H. Grabowski and J. Vernon, "A new look at the returns and risks to pharmaceutical R&D," Manage. Sci., vol. 36, pp. 804-821, July 1990.
17. ____, "Returns to R&D on new drug untroductions in the 1980s," J. Health Econ., vol. 13, pp. 383-406, 1994.
18. R. M. Grant, "The resource-based theory of competitive advantage: Implications for strategy formulation," Calif. Manage. Rev., pp. 114-135, Spring 1991.
19. S. B. Graves, "Institutional ownership and corporate R&D in the computer industry," Acad. Manage. J, vol. 31, pp. 417-428, 1988.
20. Z. Griliches, "Research cost and social returns: Hybrid corn and related inovations," J. Pol. Econ., vol. 66, pp. 419-431, 1958.
21. ____, "Issues in assessing the contribution of research and development to productivity growth," Bell J. Econ., vol. 10, pp. 92-116, 1979.
22. ____, "Market value, R&D, and patents," Econ. Lett., vol. 7, pp. 183-187, 1981.
23. ____, "Econometric results and measurement issues," in Handbook of the Economics of Innovation and Technological Change, P. Stoneman, Ed. Cambridge, MA: Blackwell, 1995, pp. 52-89.
24. ____, R&D and Productivity: The Econometric Evidence. Chicago, IL: Univ. Chicago Press, 1998.
25. R. Hall, "The strategic analysis of intangible resources," Strat. Manage. J., vol. 13, pp. 137-144, 1992.
26. A. M. Hicks and D. H. Swank, "Politics, institutions, and welfare spending in industrialized democracies, 1960-82," Amer. Pol. Sci. Rev., vol. 86, pp. 658-674, Sept. 1992.
27. C. P. Himmelberg and B. C. Petersen, "R&D and internal finance: A panel study of small firms in high-tech industries," Rev. Econ. Stat., 76, pp. 38-51, 1994.
28. A. B. Jaffe, "Technological opportunity and spillovers of R&D: Evidence from firms' patents, profits, and market value," Amer. Econ. Rev., vol. 76, pp. 984-1001, Dec. 1986.
29. J. E. Jankowski, "R&D: Foundation for innovation," Res. Technol. Manage., vol. 41, pp. 14-20, Mar./Apr. 1998.
30. B. Lev and T. Sougiannis, "The capitalization, amortization, and value-relevance of R&D," J. Account. Econ., vol. 21, pp. 107-138, 1996.
31. E. Mansfield, Industrial Research and Technological Innovation: An Econometric Analysis. New York: Norton, 1968.
32. ____, "Basic research and productivity increase in manufacturing," Amer. Econ. Rev., vol. 70, pp. 863-873, 1980.
33. J. R. Minasian, "The economics of research and development," in The Rate and Direction of Inventive Activity: Economic and SocialFactors, R. R. Nelson, Ed. Princeton: Princeton Univ. Press, 1962, pp. 93-142.
34. C. Mishra and D. Gobeli, "Managerial incentives, internalization, and market valuation of multinational firms," J. Int. Bus. Stud., vol. 29, pp. 583-597, 1998.
35. G. K. Morbey, "R&D: Its relationship to company performance," J. Prod. Innov. Manage., vol. 5, pp. 191-200, 1988.
36. F.C. Pampel, "Relative cohort size and fertility: The socio-political context of the easterlin effect," Amer. Sociol. Rev., vol. 58, pp. 496-513, August 1993.
37. R. W. Parks, "Efficient estimation of a system of regression equations when disturbances are both correlated," J. Amer. Stat. Assoc., vol. 62, pp. 500-509, June 1967.
38. S. B. Perfect and K. W. Wiles, "Alternative constructions of Tobin's Q: An empirical examination," J. Empir. Fin., vol. 1, pp. 313-341, 1994.
39. M. E. Porter, "What is strategy," Harv. Bus. Rev., pp. 61-78, Nov.-Dec. 1996.
40. D. Ravenscraft and F. M. Scherer, "The lag structure of returns to research and development," Appl. Econ., vol. 14, pp. 603-620, 1982.
41. A. M. Sapienza, "Setting the record straight: The office of technology assessment report - Pharmaceutical R&D costs, risks, and rewards," Drug Develop. Res., vol. 30, no. 2, pp. 56-60, Oct. 1993.
42. F. M. Scherer, "Corporate inventive output, profit and growth," J. Pol. Econ., vol. 73, pp. 290-297, 1965.
43. M. Statman, "Competition in the pharmaceutical industry: The declining profitability of drug innovation," in Proc. Amer. Enterprise Institute for Public Policy Research, Washington, DC, 1983.
44. T. Terwiesch, C. Loch, and M. Niederkofler, "When product development performance makes a difference: A statistical analysis in the electronics industry," J. Prod. Innov. Manage., vol. 15, pp. 3-15, Jan. 1998.
45. S. Vogt, "The cash flow/investment relationship: Evidence from U.S. manufacturing firms," Fin. Manage., vol. 23, pp. 3-20, 1994.
46. R. Wakasugi and F. Koyata, "R&D, firm size and innovation outputs: Are Japanese firms efficient in product development," J. Prod. Innov. Manage., vol. 14, pp. 381-390, Sept. 1997.